BTZ-043
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BTZ-043, covering 2022-08-10 to 2024-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment [Phase 1]